首页> 外国专利> Use of (11beta, 17beta) -11- (1,3-benzodioxol-s-yl) -17-hydroxy-17- (1-propynyl) estra-4,9-dien-3-one, pharmaceutical preparation, and, Method for treating a patient suffering from severe depressive disorder

Use of (11beta, 17beta) -11- (1,3-benzodioxol-s-yl) -17-hydroxy-17- (1-propynyl) estra-4,9-dien-3-one, pharmaceutical preparation, and, Method for treating a patient suffering from severe depressive disorder

机译:(11beta,17beta)-11-(1,3-苯并二恶唑-s-基)-17-羟基-17-(1-丙炔基)estra-4,9-dien-3-one的用途,药物制剂,和,治疗患有严重抑郁症的患者的方法

摘要

"USE OF (11 BETA, 17BETA) - 11- (1,3-BENZODIOXOL-5-IL) -17-HYDROXI-17- (1-PROPINYL) STRA-4,9-D IEN-3-ONA, PHARMACEUTICAL PREPARATION , AND, METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM SERIOUS DEPRESSIVE DISORDER ". The present invention relates to the use of glucocorticoid receptor antagonist (11?, 17?) - 11- (1,3-benzodioxol-5-yl) -17-hydroxy-17- (1-propynyl ) estra-4,9-dien-3-one (Org 34517) for the preparation of a medicament for treating depression, as well as pharmaceutical preparations of Org 34517 for said use.
机译:“使用(11 BETA,17BETA)-11-(1,3-苯二恶酚-5-IL)-17-羟基-17-(1-丙炔基)STRA-4,9-D IEN-3-ONA,药物制备,以及治疗患有严重抑郁症的患者的方法。”本发明涉及糖皮质激素受体拮抗剂(11′,17′)-11-(1,3-苯并二氧杂-5-基)-17-羟基-17-(1-丙炔基)雌激素-4,9-的用途。 dien-3-one(Org 34517)用于制备治疗抑郁症的药物,以及上述用途的Org 34517药物。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号